Recommendations will help organizations that appraise new drugs establish whether their use will result in longer-term benefits for patients
Four ...
Latest News
Canada’s Drug Agency is seeking to expand the group of scientists who contribute their expertise to our organization and help us power evidence ...
Consultation status: Open Consultation period: January 6 to February 6, 2025
Canada’s Drug Agency is outlining additional plans to modernize the drug ...
Canada's Drug Agency (CDA-AMC) and the Canadian Institute for Health Information (CIHI) have signed a 3-year agreement that will leverage the ...
Canada’s Drug Agency has received a letter from The Honourable Mark Holland that outlines our time-limited work related to An Act respecting ...
Canada’s Drug Agency is proud to welcome Maureen Smith as the first-ever Patient Member on our Board of Directors. Maureen is a respected leader in ...
Upcoming Events
All Upcoming EventsHealth Economics: Demystifying the Myths and Unlocking Its Value
Town Hall on Appropriate Use Strategy
Symposium 2024
Symposium 2024 is a 3-day hybrid event that gathers leaders from across Canada with expertise in policy, industry, health technology assessment, patient advocacy, medicine, public health, and communications. The theme of Symposium 2024 is From Disruption to Opportunity: Embracing Change in Health Care.
